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Abstract 
Metastases in Meckel’s cave are a rare tumor entity and should be considered as important differential diagnosis, espe-
cially if the patient presents with trigeminal neuralgia and suffers from a known primary malignancy. We present three 
cases of patients with secondary trigeminal neuralgia caused by a metastasis in Meckel’s cave, treated by microsurgery 
and fractionated radiation therapy. Differential diagnoses are discussed on the basis of preoperative neuroradiological 
imaging. MRI is the preferred diagnostic modality, whereas complementary CT may be needed for evaluation of early bone 
invasion. 
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Metastasen im Cavum Meckeli. Eine differentialdiagnostische Herausforderung 
Zusammenfassung 
Das Cavum Meckeli ist ein seltener Manifestationsort tumoraler Metastasen. Bei Patienten mit bekannter maligner Tu-
morerkrankung, die unter einer Trigeminusneuralgie leiden, sollte jedoch die Metastasierung des Cavum Meckeli in diffe-
rentialdiagnostische Betrachtungen einbezogen werden. Wir präsentieren drei Fälle mit sekundärer Trigeminusneuralgie 
infolge Metastasierung des Cavum Meckeli. Alle drei Patienten wurden mittels Mikroneurochirurgie und fraktionierter 
Radiotherapie behandelt. Die Magnetresonanztomographie ist die Methode der Wahl in der Evaluation neuroradiologischer 
Differentialdiagnosen. Die Computertomographie ist sehr hilfreich zur Beurteilung knöcherner Arrosionen. 
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Clinical
Introduction 
Meckel’s cave is a cerebrospinal fluid (CSF) filled space 
in a small depression anterior to the petrous apex 
formed by two layers of the dura mater. The trigeminal 
nerve enters through an oval dural opening, the porus 
trigeminus, in the posterior wall of this cavity [1]. The 
nerve trunk, composed of numerous small fibres, ex-
pands to form the sickle-shaped trigeminal (Gasserian 
or semilunar) ganglion, which lies in the anterior-infe-
rior aspect of Meckel’s cave and occupies 10% of its 
space. The leptomeninges form the trigeminal cistern, 
a subarachnoid space filled with CSF surrounding the 
nerve and ganglion within Meckel’s cave. 
Distal to the Gasserian ganglion the trigeminal 
nerve trifurcates into its main branches: the ophthalmic 
(V1), maxillary (V2) and mandibular (V3) nerves. The 
ophthalmic and maxillary divisions course within the 
cavernous sinus along its lateral wall before they run 
extracranially via the superior orbital fissure and the fo-
ramen rotundum, respectively. The mandibular nerve 
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does not transverse the cavernous sinus but travels in 
a short segment anterior-inferiorly along the skull base 
and exits through the foramen ovale [2]. 
A diverse array of pathologies can involve the tri-
geminal nerve. Differential diagnosis depends on lesion 
location, the patient’s history and clinical symptoms, 
as well as imaging characteristics. Tumors in Meckel’s 
cave are rare lesions. Schwannomas and meningiomas 
represent the majority of masses at this site. Other rare 
entities include lymphoma and perineural spread of tu-
mor [3]. In distinction to this last entity, which occurs as 
a continuous spread of head and neck cancer along the 
branches of the trigeminal nerve, we report three cases 
of hematogenous or CSF metastases in Meckel’s cave 
rarely reported up to now. 
Case Reports 
We report three cases, two male, one female, mean age 
61 (51 to 71 years), with a metastasis in Meckel’s cave 
spreading along the trigeminal nerve. In two patients a 
primary tumor was known (breast and clear cell kidney 
cancer). In the third patient, despite extensive tumor 
searching, no primary tumor site was found, but histo-
logical and immunohistochemical examination with ex-
pression of cytokeratins and p53 showed clear evidence 
of a carcinoma metastasis. All patients were treated 
with surgery and fractionated radiation therapy. 
At admission, all patients presented with trigeminal 
neuralgia in two or three trigeminal roots, lasting from 
one month to one year. Pain could be triggered by touch 
and analgesia dolorosa was found in the same region. 
Two patients did not show any corneal reflex on the af-
fected side. Additionally, one patient showed a palsy of 
the third, forth and sixth cranial nerves, progressive over 
the last six month. Preoperatively contrast-enhanced 
MR scans were performed in all patients. 
Case 1 
Case 1 was a 51-year-old female with known breast 
cancer suffering from trigeminal neuralgia in all three 
trigeminal roots. She did not show any corneal reflex. 
MR-imaging showed a tumorous lesion along the tri-
geminal nerve in its cisternal, prepontine segment and 
Meckel’s cave (Figures 1a and b). Its anatomical exten-
Figures 1a and 1b. Patient 1: A 51-year-old woman after resection of a breast cancer. a) Coronal T2-weighted MR-image at the level of the optic chi-
asm shows a cortex isointense lesion (arrow) within the Meckel’s cave, deforming its normal anatomic appearance and involving the trigeminal 
ganglion. Neither infiltration of the cavernous sinus nor infratemporal extension was detected. The lesion was attached to the petrous apex, al-
though the bony cortical outlines were preserved. b) Contrast-enhanced coronal T1-weighted, fat-saturated MR-image at the level of the pons 
demonstrates the enhancing mass (arrow) in the anterior aspect of the left cerebellopontine cistern infiltrating the trigeminal rootlets. 
Figure 1a          Figure 1b 
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sion to the superior orbital fissure, the foramina rotun-
dum and ovale with infiltration and slight dilatation of 
the latter correlated with clinical findings. These find-
ings suggested the differential diagnosis of a metastatic 
brain tumor or a trigeminal (ganglionic) schwannoma. 
Left-sided transzygomatic subtemporal approach with 
anterior petrosectomy was performed with gross total 
tumor removal. Postoperative the patient showed com-
plete pain relief, but newly presenting third nerve palsy 
with mydriasis, ptosis and double vision, as well as a 
sixth nerve palsy which was not present before surgery. 
Histopathologic examination revealed metastases of 
breast cancer. 
Case 2 
Case 2 was a 71-year-old male after resection of clear 
cell kidney cancer presenting trigeminal neuralgia in all 
trigeminal roots. The clinical presentation was associ-
ated with the imaging findings which showed a mass le-
sion involving the entire left-sided Meckel’s cave and 
the cavernous sinus (Figures 2a to 2c). Paramedian oc-
cipito-suboccipital craniotomy on the left side was per-
Figures 2a to 2c. Patient 2: A 71-year-old man after resection of clear 
kidney cancer. a) Contrast-enhanced coronal T1-weighted, fat-satu-
rated MR-image shows an enhancing lesion (arrow) within the left 
Meckel’s cave and cavernous sinus, bulging the lateral dura of Meckel’s 
cave, infiltrating the posterior-lateral aspect of the sphenoidal sinus, 
foramina rotundum and ovale. b) Axial T2-weighted MR-image depicts 
an inhomogeneous, cortex hyperintense, extra-axial mass (arrows) 
containing multiple, intratumoral vessels consistent with flow voids. 
The tumor obliterates the Meckel’s cave and extends anterior along all 
the foramen rotundum and posterior in the cerebellopontine cistern. 
The tumor tissue extended to the orbital apex, the horizontal segment 
of the bony carotid channel and the cerebellopontine angle cistern, 
with compression of the lateral surface of the pons and mesencepha-
lon. c) Axial bone-window CT-image reveals the concentric expansion 
of the foramen ovale (arrow). Bony erosion and destruction of the 
middle cranial fossa beneath the trigeminal ganglion with expansion 
of the foramen rotundum was also present. 
Figure 2a          Figure 2b 
Figure 2c       
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formed, but the surgery had to be stopped because of 
air embolism. In a second operation with the same ap-
proach, subtotal tumor removal was performed with a 
small tumor rest left in Meckel’s cave. Histopathologic 
examination showed metastasis of clear kidney cancer. 
Because of pulmonary embolism the postoperative re-
covery was delayed. The patient had an unchanged oph-
thalmoplegia, but also new dysarthria. 
Case 3 
Case 3 was a 61-year-old male with clinical manifes-
tation of trigeminal neuralgia in the second and third 
trigeminal root and ophthalmoplegia. Imaging find-
ings revealed a mass lesion involving the Meckel’s cave 
(Figures 3a and b). Left frontotemporal craniotomy and 
subtotal tumor removal was performed, as the entire 
Meckel’s cave and part of cavernous sinus were infiltrat-
ed by the tumor. As intraoperative monitoring showed 
no response in the motor root, part of the mandibular 
nerve was resected together with the tumor. Postopera-
tive a slight reduction in trigeminal pain was found in 
this case. Metastasis of an oat cell carcinoma was re-
vealed by histopathologic examination. 
Discussion 
The Meckel’s cave may be affected either by extrin-
sic or intrinsic disease. Extrinsic lesions, usually bony 
metastases, chordoma or chondrosarcoma, destroy the 
adjacent bone and compress or secondarily infiltrate 
the Meckel’s cave. Intrinsic lesions expand Meckel’s 
cave. When the tumor becomes large enough, exerted 
pressure leads secondarily to erosion of the surround-
ing bone. Lesions may also directly extend away from 
Meckel’s cave along the trigeminal branches with en-
largement of the foramina rotundum and ovale or of 
the superior orbital fissure. Intrinsic lesions include pri-
mary tumors of the Meckel’s cave as well as secondary 
neoplasms either from perineural spread of head and 
neck malignancies or from leptomeningeal or hematog-
enous spread of a distant malignancy. Primary tumors 
of the Meckel’s cave are most frequent, usually benign 
and include trigeminal schwannomas and meningio-
mas [4]. Other lesions described in this site like amy-
loid, cholesteatoma, fibrous xanthoma, melanocytoma 
and malignant melanotic schwannoma have very low 
incidence. 
Trigeminal neuralgia involving all three divisions of 
the nerve is the most common primary symptom of a 
Meckel’s cave neoplasm [5–7], but clinical findings do 
not allow accurate localization of the lesion [8]. There-
fore, the entire course of the trigeminal nerve must be vi-
sualized from the brainstem origin to the peripheral end-
plates. MR-imaging is considered the method of choice 
for evaluating patients with trigeminal nerve disorders 
in most clinical settings [9] because it detects the full ex-
Figures 3a and 3b. Patient 3: A 61-year-old man with a metastasis of an 
oat cell carcinoma of unknown origin. a) Contrast-enhanced axial T1-
weighted, fat-saturated MR-image demonstrates an intense enhanc-
ing, enlarged left trigeminal nerve (arrows) from its root entry zone via 
cisternal segment to porus trigeminus and lateral aspect of Meckel’s 
cave. b) Contrast-enhanced coronal T1-weighted, fat-saturated MR-im-
age shows infiltration of the trigeminal ganglion by a homogenously 
enhancing mass (arrow) in the inferior-anterior-lateral aspect of 
Meckel’s cave. Note enhancement and thickening of the mandibular 
nerve extending from the trigeminal ganglion slightly extracranially 
via the foramen ovale to the masticator space. The normal CSF signal 
of Meckel’s cave is diminished. 
Figure 3a  
Figure 3b  
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tent of lesion especially in the basal cisterns and skull 
base [10] and displays intradural tumor components. 
MR-imaging was the primary modality used for the 
investigation of the three above mentioned patients 
with trigeminal neuralgia. In the first two cases medical 
history and lesion morphology were considered to be 
consistent with metastatic disease. Metastatic pathways 
through which malignant tumors involve the trigeminal 
nerve or ganglion can be divided into CSF dissemina-
tion, hematogenous spread from extracranial primary 
sites and continued invasion from extracranial malig-
nancies such as nasopharyngeal, maxillo-facial and in-
fratemporal fossa tumors via the adjacent dura or bone 
[11]. The occurrence of metastases in Meckel’s cave is 
described for esophageal and colorectal adenocarcino-
ma as well as breast carcinoma [5, 6, 12]. Intracranial 
metastases of the ophthalmic (V1), maxillary (V2) and 
mandibular (V3) nerves or the trigeminal nerve trunk 
have been reported previously with follicular carcinoma 
of the thyroid [13], systemic lymphoma [14], hepatocel-
lular carcinoma, ovarian cancer and melanoma of the 
skin [15–17]. 
Brain metastases from breast cancer are among the 
most common hematogenous metastases and occur typ-
ically 42 to 60 months after the diagnosis of the primary 
lesion – a longer period than other types of cancer [12]. 
This is in consistence with our first case of breast cancer 
presenting symptoms of trigeminal neuralgia 48 months 
after primary tumor resection, whereas in the patient 
with kidney cancer symptoms arised 15 months after re-
section of the primary tumor. 
In the case of the woman suffering from breast can-
cer the radiographic characteristics of the lesion in the 
middle cranial fossa were interpreted as being consistent 
with schwannoma, or even malignant schwannoma, or a 
lymphoma, too. Schwannomas of the trigeminal nerve 
are the second most common cranial nerve schwanno-
mas. These usually isolated lesions present with loss of 
function of the affected nerve segment but they can also 
be clinically silent. The slight foraminal enlargement in 
our case made the diagnosis of schwannoma possible. 
Primary malignant schwannomas of the trigeminal 
nerve are rare entities, especially starting from the tri-
geminal ganglion [18]. 
Malignant lymphomas can also arise in the trigemi-
nal nerve, spread into the Meckel’s cave or through the 
foramen ovale. They are also isointense on T1- and T2-
weighted MR-images with homogenous gadolinium en-
hancement. Primary central nervous system lymphoma 
is rare but can affect the cavernous sinus and Meckel’s 
cave especially in high-risk immuno-compromised [19, 
20]. De Pena et al. described an isolated lymphoma me-
tastasis involving the cisternal segment of the trigeminal 
nerve and the Gasserian ganglion via CSF [21]. In most 
cases concomitant involvement of other cranial nerves 
is present at the time of diagnosis. 
Metastasis from kidney cancer in Meckel’s cave has 
not been previously reported. The strongly enhancing, 
infiltrative, partially irregular marginated lesion in the 
second patient was also suspected of a hemangioperi-
cytoma due to the presence of multiple intralesional 
flow voids. Hemangiopericytomas are rare intracranial, 
dural-based, malignant tumors, representing 2 to 4% of 
meningeal tumors. They show multilobular or irregular 
margins, strong contrast enhancement and typically no 
signs of calcification or hyperostosis, an important dis-
tinguishing feature [22]. 
An exceptionally rare entity to include in a differ-
ential diagnosis is the granular-cell-tumor (granular-
cell myeloblastoma) of the trigeminal nerve. Carvalho 
et al. reported a case of this tumor on the level of tri-
geminal ganglion and Meckel’s cave that invaded the 
cavernous sinus, enlarged the foramen ovale, partially 
destroyed the petrous apex and enhanced homog-
enously [23]. 
The third patient had no history of a primary malig-
nancy. This made the correct diagnosis more challeng-
ing. Enhancement of the trigeminal ganglion is normal 
and routinely visible on MR-images [24]. Occasionally 
even the normal proximal V2 or V3 divisions and nerve 
sheath may enhance [1, 8]. This should not be confused 
with pathologic entities particularly if the patients are 
asymptomatic. The combination of enhancement and 
enlargement of a nerve is pathologic due to inflamma-
tory or infectious disorders, such as inflammatory pseu-
dotumor, viral neuritis, sarcoidosis and histiocytosis. 
Whereas neurosarcoidosis can involve the trigeminal 
nerve or ganglion, viral encephalitis, herpes neuritis 
and Lyme disease affect the preganglionic, cisternal seg-
ment, too [4]. The involvement of this trigeminal nerve 
segment in the third patient led us to the primary diag-
nosis of an inflammatory process. 
A tumoral process was also included in the differen-
tial diagnosis. Because of the relatively circumscribed 
lesion morphology and the minimal meningeal enhance-
ment we considered a schwannoma as a more likely di-
agnosis than a meningioma. Meningiomas of Meckel’s 
cave can involve the Gasserian ganglion or/and the pre-
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ganglionic, cisternal segment as well as the main branch-
es of the trigeminal nerve and meningiomas en plaque 
embedded in the ganglion have been described [7]. On 
MRI meningiomas and metastases appear as isointense 
in T2-weighted images and iso- to hypointense lesions in 
T1-weighted images with an intense contrast enhance-
ment. Apparent dural tail and hyperostosis as distin-
guishing feature of a meningioma were not found in our 
case. This makes the differential diagnosis more diffi-
cult, especially if there are no coexisting brain metasta-
ses and therefore a possible metastasis was included in 
the differential diagnosis. 
Similar imaging characteristics are also found with 
other neoplastic diseases, such as perineural tumor in-
filtration. Imaging signs of perineural tumor extension 
along the trigeminal nerve include abnormal nerve 
thickening with enhancement, concentric expansion or 
erosion of related skull base foramina and extracranial 
nerve canals. Furthermore replacement of the normal 
trigeminal cistern hypointensity on T1-weighted or hy-
perintensity on T2-weighted images by an isointense 
mass, enhancement within Meckel’s cave, the trigemi-
nal cistern or at the root entry zone of the trigeminal 
nerve, lateral bulging of the cavernous sinus and dural 
membranes, and denervation atrophy of the masticator 
muscles [1, 25, 26]. Perineural tumor extension is most 
commonly seen with head and neck carcinomas of cu-
taneous and mucosal origin, particularly the squamous 
cell carcinoma, adenoid cystic carcinoma, malignant 
melanoma and basal cell carcinoma [25, 27]. Additional 
tumor types like lymphoma, mucoepidermoid carci-
noma, adenocarcinoma and sarcoma, schwannoma and 
neurofibroma are reported to spread retrogradely via 
perineural route and to reach eventually the foramen 
ovale [8]. The mandibular division of the trigeminal 
nerve is most commonly involved because of its exten-
sive branches and connections involving the facial struc-
tures and neck [26]. Peritumoral spread in the Gasserian 
ganglion occurs in 40% of patients with malignant pe-
ripheral lesions, by far the most often being squamous 
cell carcinoma of the face [10]. 
Perineural tumor spread into Meckel’s cave is best 
seen on post-contrast coronal T1-weighted images us-
ing fat saturation. The MR-study of our third patient 
revealed a smooth, isointense thickening of V3 and 
moderate concentric enlargement of the foramen ovale. 
The replacement of the normal signal intensity of the 
trigeminal cistern in T1-weighted images by an isoin-
tense mass indicated ganglionic involvement. 
It is important that perineural tumor spread alters 
treatment and prognosis. Surgical removal of these 
tumors enables the confirmation of the diagnosis and 
amelioration of trigeminal pain. In consideration of the 
postoperative quality of life, the radicality of surgical 
treatment should be planned according to the tumor ex-
tension and possibly combined with adjuvant radiation 
therapy. 
We conclude that knowledge of the anatomic course 
of the trigeminal nerve as well as patient’s history facili-
tate early diagnosis, correct estimation of tumor extend 
and guide the appropriate treatment. Despite metasta-
sis of Meckel’s cave, Gasserian ganglion and trigeminal 
nerve is rare, it should be taken into differential diag-
nostic thinking, especially in patients with a known pri-
mary malignancy. 
High-resolution MR-imaging should be used to fol-
low tumor spread along the nerve, its adjacent struc-
tures and potentially intradural extent. CT provides ad-
ditional information related to involvement of the bony 
skull base foramina. 
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